On Friday, Shares of Momo Inc (ADR)(NASDAQ:MOMO), subtract -1.32% and closed at $22.50 in the last trading session. The last trading range of the stock ranges between $22.31 and $23.19. Momo Inc. operates as a mobile-based social networking platform in the Peoples Republic of China. The companys platform includes its Momo mobile application and various related features, functionalities, tools, and services that are offered to users, customers, and platform partners. Its Momo mobile application facilitates users to establish and expand their social relationships based on locations and interests. The company also offers games, which are designed with various themes, cultural characteristics, and features to appeal to various segments of the game player community; paid emoticons and mobile marketing services; and live music and entertainment broadcasting services.
Immune Pharmaceuticals Inc (NASDAQ:IMNP), jumped 8.80% and closed at $0.283 in the last trading session. The last trading range of the stock ranges between $0.26 and $0.28. The company’s Market capitalization is $31.28 million with the total Outstanding Shares of 101.58 million. Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The companys lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn’s disease. It is also developing NanoCyclo, a topical nanocapsule formulation of cyclosporine, for the treatment of psoriasis and atopic dermatitis; Ceplene, a small molecule, which has accomplished Phase III clinical trials targeting the Histamine-2 Receptor to overcome immunosuppression in Acute Myeloid Leukemia and other malignancies; Azixa, a Phase II clinical trial novel microtubular destabilizer that functions as a vascular disruption agent; and Crolibulin, a novel small molecule vascular disruption agent and apoptosis inducer, which is in Phase II clinical trials for the treatment of patients with solid tumors. The companys products also include NanomAbs technology platform, an antibody-drug conjugate platform for the treatment of cancer; novel technology platform for the construction of bispecific antibodies for immunotherapies; and AmiKet, a prescription topical analgesic cream, which is in Phase III clinical trial to treat peripheral neuropathies. It has license, and other collaborative research and development arrangements with BioNanoSim Ltd.; Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.; Atlante Biotech SAS; Shire Biochem, Inc.; Lonza Sales AG; MabLife SAS; iCo Therapeutics Inc.; Dalhousie University; and Endo Pharmaceuticals Inc.
Swift Transportation Co (NYSE:SWFT), jumped 0.61% and closed at $21.47 in the last trading session. The last trading range of the stock ranges between $21.23 and $21.64. During the 52-week trading session the minimum price at which share price traded, registered at $11.74 and reached to max level of $22.15. Swift Transportation Company operates as a multi-faceted transportation services company in North America. The company operates through four segments: Truckload, Dedicated, Swift Refrigerated, and Intermodal. The Truckload segment provides services through one-way movements over irregular routes utilizing companys and owner-operator tractors with dry van, flatbed, and specialized trailing equipment in the United States, Mexico, and Canada. The Dedicated segment offers tailored solutions under long-term contracts utilizing refrigerated, dry van, flatbed, and other specialized trailing equipment. The Swift Refrigerated segment mainly offers shipments for customers who require temperature-controlled trailers. This segments shipments include one-way movements over irregular routes, in addition to dedicated truck operations. The Intermodal segment moves freight over the rail in containers and other trailing equipment; and provides drayage services to transport loads between the railheads and customer locations. The company also offers logistics and freight brokerage services, in addition to support services to its customers and owner-operators, counting repair and maintenance shop services, equipment leasing, and insurance. As of December 31, 2015, it operated a fleet of 15,211 company tractors and 4,653 owner-operator tractors; 65,233 trailers; and 9,150 intermodal containers from 40 terminals near key freight centers and traffic lanes. Swift Transportation Company serves various customers mainly in the retail, food and beverage, consumer products, paper products, transportation and logistics, housing and building, automotive, and manufacturing industries.